Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

BACKGROUND: Hydroxyurea prevents disease complications among patients with sickle cell disease (SCD). Although its efficacy has been endorsed by the National Health Lung and Blood Institute evidence-based guidelines, its adoption is low, both by patients with SCD and providers. Mobile health (mHealt...

Descripción completa

Detalles Bibliográficos
Autores principales: Hankins, Jane S, Shah, Nirmish, DiMartino, Lisa, Brambilla, Donald, Fernandez, Maria E, Gibson, Robert W, Gordeuk, Victor R, Lottenberg, Richard, Kutlar, Abdullah, Melvin, Cathy, Simon, Jena, Wun, Ted, Treadwell, Marsha, Calhoun, Cecelia, Baumann, Ana, Potter, Michael B, Klesges, Lisa, Bosworth, Hayden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388044/
https://www.ncbi.nlm.nih.gov/pubmed/32442144
http://dx.doi.org/10.2196/16319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388044/
https://www.ncbi.nlm.nih.gov/pubmed/32442144
http://dx.doi.org/10.2196/16319

Ejemplares similares